- Rules-Based Medicine 3300 Duval Road Austin, TX 78759 USA
19 November 2009 - Covance has entered into a biomarker alliance and services agreement with Rules-Based Medicine, a provider of multiplexed-protein-biomarker testing to the pharmaceutical industry.
Rules-Based Medicine has announced the availability of DiscoveryMap v1.0 - a collection of quantitative immunoassays for use in advancing safety and efficiency in drug and diagnostic development.
Rules-Based Medicine has commercialised a new biomarker panel to aid pharmaceutical and biotech companies evaluate renal toxicity in rats for pre-clinical drug trials
Rules-Based Medicine (RBM) is partnering with Psynova Neurotech to co-develop and commercialise a blood test for the diagnosis of schizophrenia